Lifecore Biomedical Inc (LFCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1176)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

Prossima data di guadagno

Ultimi documenti SEC

LFCR's Discussions on Twitter

Confronta LFCR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LFCR Lifecore Biomedical Inc	6.56	242.89M	128.45M	6.54M	-8.79M	0.05
ZTS Zoetis Inc	167.53	75.58B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.24	41.78B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.82	24.72B	16.77B	-959.00M	1.37B	-0.85
NBIX Neurocrine Biosciences Inc	145.88	14.77B	2.24B	385.90M	440.10M	3.73

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-05	Iniziato	Craig Hallum	Buy
2024-08-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2023-03-20	Downgrade	Stephens	Overweight → Equal-Weight

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Confronta LFCR con altri titoli

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

(LFCR) Technical Data - Stock Traders Daily

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat

Lifecore Biomedical Announces Special Stockholder Meeting - The Manila Times

Lifecore Biomedical Calls Special Meeting to Vote on Preferred Stock Conversion Cap Removal - StockTitan

Jane Street Group LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - AccessWire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - AccessWire

LFCR FY2025 EPS Forecast Boosted by Barrington Research - Defense World

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - AccessWire

LFCR FY2025 EPS Forecast Lifted by Barrington Research - MarketBeat

Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical - Simply Wall St

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire

Lifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 Shares - MarketBeat

Geode Capital Management LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World

Barclays PLC Has $147,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World

Lifecore Biomedical to sell multi-purpose 10-head isolator filler - MSN

Lifecore Biomedical Sells Excess Capital Equipment for $17M - Contract Pharma

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million - The Manila Times

Lifecore Biomedical Secures $17M Equipment Sale, Doubles Production Capacity with New Filler - StockTitan

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - AccessWire

Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm - AccessWire

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript - MSN

Lifecore Biomedical’s (LFCR) “Equal Weight” Rating Reaffirmed at Stephens - Defense World

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - AccessWire

Lifecore stock reaffirmed at Equal Weight at Stephens following Q2 results By Investing.com - Investing.com Canada

Lifecore Biomedical's (LFCR) "Equal Weight" Rating Reaffirmed at Stephens - MarketBeat

Further weakness as Lifecore Biomedical (NASDAQ:LFCR) drops 11% this week, taking three-year losses to 38% - Simply Wall St

US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus - Benzinga

Lifecore Biomedical: Fiscal Q2 Earnings Snapshot - Midland Daily News

Lifecore Biomedical earnings beat by $0.02, revenue topped estimates - Investing.com UK

Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga

Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... By GuruFocus - Investing.com Canada

Earnings call transcript: Lifecore Biomedical Q2 2024 sees revenue growth, stock dips - Investing.com Australia

Lifecore Biomedical Reports Q2 Fiscal 2025 Results - TipRanks

Lifecore Biomedical Inc (LFCR) Q2 Fiscal 2025 Earnings: EPS Loss - GuruFocus.com

Lifecore Biomedical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 24, 2024 - Marketscreener.com

Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates - MSN

Stocks to Watch: Lifecore Biomedical, Resources Connection - MarketWatch

Lifecore Biomedical Inc. (LFCR) reports earnings - Quartz

Lifecore Biomedical (NASDAQ:LFCR) Issues Earnings Results - MarketBeat

Lifecore Biomedical Swings to 2Q Loss Despite Higher Sales - MarketWatch

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update - The Manila Times

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate - The Bakersfield Californian

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Acquired by State Street Corp - Defense World

Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 202 - GuruFocus.com

Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result - Yahoo Finance

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LFCR